A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

BACKGROUND: Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor subsets most amenable to angiogenesis modulation are lacking. METHODS: We prof...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pentheroudakis, George, Kotoula, Vassiliki, Fountzilas, Elena, Kouvatseas, George, Basdanis, George, Xanthakis, Ioannis, Makatsoris, Thomas, Charalambous, Elpida, Papamichael, Demetris, Samantas, Epaminontas, Papakostas, Pavlos, Bafaloukos, Dimitrios, Razis, Evangelia, Christodoulou, Christos, Varthalitis, Ioannis, Pavlidis, Nicholas, Fountzilas, George
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933361/
https://ncbi.nlm.nih.gov/pubmed/24555920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-111
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker